Clinical Practice Guidelines, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 3.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cqf-recommendations/ and changes regularly. See the Directory of published versions
This page was reorganized and editorially revised in this version of the guide (see FHIR-59639 in the change log).
Guideline development consists of a community of practice made up of numerous professionals with expertise and skills in various clinical/scientific fields. This implementation guide does not describe the guideline development process in complete detail. However, it gives an overview to provide sufficient context for the rest of the implementation guide since the scope for the CPG is to provide a computer-interpretable representation of the final work product of the guideline development process.
This section covers:
Clinical practice guidelines are systematically developed statements to assist clinical practitioner and patient decisions about appropriate care for specific clinical conditions, procedures, and/or similarly scoped activities. Guidelines consist of recommendations for patient care, which are based on scientific research and data (evidence), vetted through rigorous processes of a review and synthesis by recognized domain and methodological experts and other key stakeholders (e.g. patient and caregiver advocates) to guide healthcare decisions and activities for defined scope. A guideline may consist of one or more recommendations, contextualizing information, the possible means or strategies for bringing together or orchestrating recommendations, and other relevant considerations. A recommendation is a proposal pertaining to the best course of action put forth by an authoritative source or body (e.g. governmental or professional society convened guideline development group). More detailed descriptions of and best practices for the guideline development process may be found at numerous publicly available resources (e.g., https://www.ncbi.nlm.nih.gov/books/NBK209539/pdf/Bookshelf_NBK209539.pdf; https://cebgrade.mcmaster.ca/guidelinechecklistonline.html; https://doi.org/10.7326/0003-4819-153-3-201008030-00010; https://www.nccih.nih.gov/health/providers/clinicalpractice) and are beyond the scope of this document, though a few key concepts will be covered.
The guideline development group is the multi-stakeholder, cross-functional team assembled to develop the guideline. It often includes members from the target audience (specialist and primary care clinicians), content experts, patients and caregivers, front-line clinicians, evidence-based practice experts, outcomes and quality experts, usability experts, experts in medical and shared decision-making, methodology experts, and experts in health economics. (https://cebgrade.mcmaster.ca/guidelinechecklistonline.html#GuidelineGroupMembershiptable).
For the digital CPG, we will need to add a few more experts to the guideline development group or have a few key resources serve cross-functional roles with a Knowledge engineering team (see Knowledge Engineering). These may include experts in creating computable representations of the guideline such as: knowledge extraction and/or elicitation, terminologists and/or ontologists, clinical research informatics (ref), clinical informatics, clinical decision support, cognitive informatics, knowledge formalism and expression, measurement science and measure development, user experience (UX), and user-centered design. These experts often start with a “paper” or narrative guideline but will likely produce much higher fidelity, accurate, and usable expressions of the guideline through a more “agile” approach to concurrent, integrated, and cross-functional approach to guideline development and knowledge engineering.
Scoping refers to the process and establishment of criteria to describe and constrain the focus of the guideline. It addresses who is the target user of the guideline, who it applies to, and what is addressed in the guideline. This is typically based on various factors, including high prevalence and burden of disease, avoidable mortality and morbidity, high cost, emerging diseases or emerging care options, variation in clinical practice, and rapidly changing evidence. The PICOTS Typology (i.e., population, intervention, comparison, outcome, timeframe) is often used in scoping and correlates closely to the eligibility criteria for the CPG (https://cebgrade.mcmaster.ca/guidelinechecklistonline.html#Prioritytable).
Frameworks such as the Evidence Pyramid, the PICOTS typology, and GRADE are used to synthesize and grade evidence and to scope guidelines and recommendations. See Guideline Development Frameworks.
A computable CPG enables the highest ("Systems") level of the 6S Evidence Pyramid, in which evidence is integrated with individual patient records, and supports the feedback loops of a Learning Health System. See 6S Evidence Pyramid and Learning Health Systems.
The guideline development group analyzes the evidence, formulates recommendations (with their direction, strength, and quality of evidence), and reports and disseminates the guideline. See Analysis of Evidence, Recommendations, and Reporting.
Computable artifacts (recommendations, strategies, pathways, metrics, measures, and case reports) can be co-developed with the narrative guideline through an integrated process. See Development of Computable Clinical Guideline Artifacts.